6 patents
Utility
Galectin-3 plasmapheresis therapy
19 Jul 22
The invention is directed to the removal of serum gal-3 from circulation by plasmapheresis, comprising at least in part donor apheresis, using gal-3 binding agents in either a fixed bed, or in a form easily removed, such as by being complexed with magnetic particles.
Isaac Eliaz
Filed: 18 Nov 19
Utility
Galectin-3 plasmapheresis therapy
19 Jul 22
The invention is directed to the removal of serum gal-3 from circulation by plasmapheresis, comprising at least in part donor apheresis, using gal-3 binding agents in either a fixed bed, or in a form easily removed, such as by being complexed with magnetic particles.
Isaac Eliaz
Filed: 18 Nov 19
Utility
Galectin-3 plasmapheresis therapy
19 Jul 22
The invention is directed to the removal of serum gal-3 from circulation by plasmapheresis, comprising at least in part donor apheresis, using gal-3 binding agents in either a fixed bed, or in a form easily removed, such as by being complexed with magnetic particles.
Isaac Eliaz
Filed: 18 Nov 19
Utility
Galectin-3 plasmapheresis therapy
12 Oct 21
The invention is directed to the removal of serum gal-3 from circulation by plasmapheresis, comprising at least in part donor apheresis, using gal-3 binding agents in either a fixed bed, or in a form easily removed, such as by being complexed with magnetic particles.
Isaac Eliaz
Filed: 28 Jan 19
Utility
Plasmapheresis device
23 Mar 21
A plasmapheresis device includes a column or other flow mechanism in which plasma flows following separation of the plasma from cellular components like blood cells, platelets and the like.
Isaac Eliaz
Filed: 20 May 14
Utility
Patient selective apheresis
9 Nov 20
A system and method for the practice of apheresis employs modules in the system which can be selected for a particular patient to treat particular situations or combinations of difficulties.
Isaac Eliaz
Filed: 27 Mar 16
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first